Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dose reduction and discontinuation of biological therapy in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: Protocol for a 18 months randomised, open label, parallel-group, multi-centre trial

Next Previous
X
Search
Trial Profile

Dose reduction and discontinuation of biological therapy in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: Protocol for a 18 months randomised, open label, parallel-group, multi-centre trial

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Jul 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Abatacept (Primary) ; Adalimumab (Primary) ; Certolizumab pegol (Primary) ; Etanercept (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Infliximab (Primary) ; Tocilizumab (Primary)
  • Indications Ankylosing spondylitis; Axial spondyloarthritis; Psoriatic arthritis; Rheumatoid arthritis; Spondylarthritis
  • Focus Therapeutic Use
  • Acronyms BIODOPT

    • Most Recent Events

    • 03 Jun 2023 Results exploring tumour necrosis factor inhibitor drug levels during disease activity guided tapering in patients with inflammatory arthritis presented at the 24th Annual Congress of the European League Against Rheumatism
    • 04 Jun 2022 Status changed from recruiting to active, no longer recruiting.
    • 04 Jun 2022 Results presented at the 23rd Annual Congress of the European League Against Rheumatism

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top